Caveolin-1: a multifaceted driver of breast cancer progression and its application in clinical treatment

Human breast cancer is one of the most frequent cancer diseases and causes of death among female population worldwide. It appears at a high incidence and has a high malignancy, mortality, recurrence rate and poor prognosis. Caveolin-1 (Cav1) is the main component of caveolae and participates in various biological events. More and more experimental studies have shown that Cav1 plays a critical role in the progression of breast cancer including cell proliferation, apoptosis, autophagy, invasion, migration and breast cancer metastasis. Besides, Cav1 has been found to be involved in chemotherapeutics and radiotherapy resistance, which are still the principal problems encountered in clinical breast cancer treatment. In addition, stromal Cav1 may be a potential indicator for breast cancer patients’ prognosis. In the current review, we cover the state-of-the-art study, development and progress on Cav1 and breast cancer, altogether describing the role of Cav1 in breast cancer progression and application in clinical treatment, in the hope of providing a basis for further research and promoting CAV1 gene as a potential target to diagnose and treat aggressive breast cancers.

[1]  D. Salomon,et al.  Identification of Caveolin-1 as a Potential Causative Factor in the Generation of Trastuzumab Resistance in Breast Cancer Cells , 2013, Journal of Cancer.

[2]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[3]  Y. Bozkaya,et al.  Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer? , 2017, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[4]  P. Cai,et al.  Sclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells , 2017, Molecular medicine reports.

[5]  R. Langer,et al.  WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells , 2013, Oncogene.

[6]  Zhi-wei Li,et al.  Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis. , 2016, Cancer letters.

[7]  M. Sliwkowski,et al.  Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2–Positive Cancer , 2011, Clinical Cancer Research.

[8]  P. Tan,et al.  Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer , 2015, Breast Cancer Research and Treatment.

[9]  Elena Clementi,et al.  Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas , 2017, International journal of molecular sciences.

[10]  D. Colomer,et al.  In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts , 2010, Clinical Cancer Research.

[11]  Wei Gu,et al.  Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence , 2012, Cell.

[12]  Hong Yang,et al.  Shear stress promotes anoikis resistance of cancer cells via caveolin‐1‐dependent extrinsic and intrinsic apoptotic pathways , 2018, Journal of cellular physiology.

[13]  Jian Liu,et al.  Bisphenol A promotes X‐linked inhibitor of apoptosis protein‐dependent angiogenesis via G protein‐coupled estrogen receptor pathway , 2015, Journal of applied toxicology : JAT.

[14]  Fei Liu,et al.  Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation , 2017, Cellular Physiology and Biochemistry.

[15]  Zhenyu Hu,et al.  Alternative Splicing of L-type CaV1.2 Calcium Channels: Implications in Cardiovascular Diseases , 2017, Genes.

[16]  Dafydd G. Thomas,et al.  Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome , 2014, Breast Cancer Research and Treatment.

[17]  M. Ansari,et al.  Very Late Relapse in Breast Cancer Survivors: a Report of 6 Cases , 2013, Iranian journal of cancer prevention.

[18]  Joshua J. Steffan,et al.  The polyphenol epigallocatechin‐3‐gallate affects lipid rafts to block activation of the c‐Met receptor in prostate cancer cells , 2010, Molecular carcinogenesis.

[19]  Xiaomeng Zhang,et al.  Caveolin-1 enhances RANKL-induced gastric cancer cell migration , 2018, Oncology reports.

[20]  F. Portillo,et al.  Transcriptional regulation of cell polarity in EMT and cancer , 2008, Oncogene.

[21]  Tim Beißbarth,et al.  mRNA Profiling Reveals Determinants of Trastuzumab Efficiency in HER2-Positive Breast Cancer , 2015, PloS one.

[22]  E. Andrechek,et al.  Triple-negative breast cancer and the potential for targeted therapy , 2017, Pharmacogenomics.

[23]  L. Tang,et al.  miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin β1 and Matrix Metalloproteinase2 (MMP2) , 2013, PloS one.

[24]  B. Schwartz,et al.  Restoration of caveolin‐1 expression suppresses growth, membrane‐type‐4 metalloproteinase expression and metastasis‐associated activities in colon cancer cells , 2013, Molecular carcinogenesis.

[25]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Laurent Ducry,et al.  Antibody-Drug Conjugates , 2013, Methods in Molecular Biology.

[27]  Olufunmilayo I Olopade,et al.  MYC in breast tumor progression , 2008, Expert review of anticancer therapy.

[28]  Annette Meeson,et al.  Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. , 2014, Cancer treatment reviews.

[29]  Y. Rojanasakul,et al.  Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells. , 2015, American journal of physiology. Cell physiology.

[30]  G. Calaf,et al.  Antitumor activity of pamidronate in breast cancer cells transformed by low doses of α-particles and estrogen in vitro. , 2015, International journal of oncology.

[31]  Xuelei Ma,et al.  Prognostic role of caveolin in breast cancer: a meta-analysis. , 2013, Breast.

[32]  Weijie Yi,et al.  Bisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxia. , 2017, Environmental pollution.

[33]  Ying Tu,et al.  MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting. , 2018, Trends in pharmacological sciences.

[34]  A. Kenworthy,et al.  Characterization of a caveolin‐1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy , 2016, Traffic.

[35]  B. Nichols,et al.  Caveolae: One Function or Many? , 2016, Trends in cell biology.

[36]  W. Zhan,et al.  Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival. , 2015, World journal of gastroenterology.

[37]  Harikrishna Nakshatri,et al.  CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.

[38]  Paola Chiarugi,et al.  Anoikis molecular pathways and its role in cancer progression. , 2013, Biochimica et biophysica acta.

[39]  G. García-Rivas,et al.  A systematic review of genetic mutations in pulmonary arterial hypertension , 2017, BMC Medical Genetics.

[40]  Z. Xiu,et al.  Effects of Antarctic krill docosahexaenoic acid on MCF‐7 cell migration and invasion induced by the interaction of CD95 with caveolin‐1 , 2018, Life sciences.

[41]  R. Hill,et al.  Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia. , 2013, Cancer letters.

[42]  V. Joulin,et al.  Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases. , 2013, Cancer research.

[43]  M. Mazzone,et al.  Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis , 2017, Cell reports.

[44]  King-Jen Chang,et al.  Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1) , 2015, PloS one.

[45]  R. Parton,et al.  Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy , 2015, Autophagy.

[46]  P. Sylvester,et al.  Antiproliferative effects of γ-tocotrienol are associated with lipid raft disruption in HER2-positive human breast cancer cells. , 2016, The Journal of nutritional biochemistry.

[47]  P. Scherer,et al.  Caveolin-1 in skin aging – From innocent bystander to major contributor , 2019, Ageing Research Reviews.

[48]  S. Wiseman,et al.  Caveolin-1 in tumor progression: the good, the bad and the ugly , 2008, Cancer and Metastasis Reviews.

[49]  G. Jerusalem,et al.  Triple-negative breast cancer: treatment challenges and solutions , 2016, Breast cancer.

[50]  Tingting Liu,et al.  Fluctuation of ROS regulates proliferation and mediates inhibition of migration by reducing the interaction between DLC1 and CAV-1 in breast cancer cells , 2017, In Vitro Cellular & Developmental Biology - Animal.

[51]  Xiu-ying Li,et al.  Expression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysis , 2017, Wiener klinische Wochenschrift.

[52]  W. Cho,et al.  The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma , 2017, OncoTargets and therapy.

[53]  D. Welch,et al.  Breast Cancer Progression: Controversies and Consensus in the Molecular Mechanisms of Metastasis and EMT , 2007, Journal of Mammary Gland Biology and Neoplasia.

[54]  M. Nowakowska,et al.  Coexpression of CAV-1, AT1-R and FOXM1 in prostate and breast cancer and normal cell lines and their influence on metastatic properties. , 2016, Acta biochimica Polonica.

[55]  M. Therkildsen,et al.  A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[56]  P. Vigneri,et al.  Cancer Stem Cells and Chemosensitivity , 2011, Clinical Cancer Research.

[57]  E. Prossnitz,et al.  Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts , 2015, Environmental health perspectives.

[58]  L. Livi,et al.  Role of Magnetic Resonance Imaging in the Preoperative Staging and Work-Up of Patients Affected by Invasive Lobular Carcinoma or Invasive Ductolobular Carcinoma , 2018, BioMed Research International.

[59]  M. Setou,et al.  Role of caveolin‐1 in hepatocellular carcinoma arising from non‐alcoholic fatty liver disease , 2018, Cancer science.

[60]  D. Nie,et al.  Cancer stem cells and resistance to chemo and radio therapy. , 2012, Frontiers in bioscience.

[61]  M. Dowsett,et al.  The role of caveolin-1 in human breast cancer , 2011, Breast Cancer Research and Treatment.

[62]  Jianping Chen,et al.  Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway. , 2014, Carcinogenesis.

[63]  C. Botta,et al.  Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. , 2015, Human pathology.

[64]  Hao Huang,et al.  Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances , 2018, Sensors.

[65]  M. Dean.  ABC Transporters, Drug Resistance, and Cancer Stem Cells , 2009, Journal of Mammary Gland Biology and Neoplasia.

[66]  S. Ye,et al.  Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis. , 2014, Biochimica et biophysica acta.

[67]  F. Beca,et al.  Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma , 2013, Cell cycle.

[68]  G. Calaf,et al.  Curcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogen. , 2016, International journal of oncology.

[69]  Daniel J. Sargent,et al.  Drug rechallenge and treatment beyond progression—implications for drug resistance , 2013, Nature Reviews Clinical Oncology.

[70]  A. Jemal,et al.  Cancer statistics: Breast cancer in situ , 2015, CA: a cancer journal for clinicians.

[71]  S. Hehlgans,et al.  Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance. , 2011, American journal of cancer research.

[72]  R. Parton,et al.  Cavin family proteins and the assembly of caveolae , 2015, Journal of Cell Science.

[73]  Fan Wang,et al.  Combined caveolin-1 and epidermal growth factor receptor expression as a prognostic marker for breast cancer. , 2018, Oncology letters.

[74]  Wenshan He,et al.  Caveolin-1 functions as a key regulator of 17β-estradiol-mediated autophagy and apoptosis in BT474 breast cancer cells. , 2014, International journal of molecular medicine.

[75]  L. Pike.  Growth factor receptors, lipid rafts and caveolae: an evolving story. , 2005, Biochimica et biophysica acta.

[76]  Faustino Mollinedo,et al.  Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. , 2007, Blood.

[77]  Nektarios Tavernarakis,et al.  Hypoxia and Selective Autophagy in Cancer Development and Therapy , 2018, Front. Cell Dev. Biol..

[78]  C. Piyathilake,et al.  Triple Negative Breast Cancer – An Overview , 2012, Hereditary genetics : current research.

[79]  H. Rui,et al.  Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer , 2009, Cancer biology & therapy.

[80]  A. Donnenberg,et al.  Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. , 2009, Methods in molecular biology.

[81]  D. Stupack,et al.  Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion , 2014, Journal of Cell Science.

[82]  J. Holly,et al.  Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism , 2018, Cancer letters.

[83]  G. Che,et al.  Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review) , 2014, Oncology letters.

[84]  O. Salis,et al.  The relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, CAV-1, HO-1, SGK-1 and Par-4) on MCF-7 cell line. , 2014, European review for medical and pharmacological sciences.

[85]  Y. Tochigi,et al.  Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours. , 2015, Veterinary journal.

[86]  Takeshi Kimura,et al.  Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice , 2018, Pulmonary circulation.

[87]  Xin Zheng,et al.  Caveolin-1 Is Up-Regulated by GLI1 and Contributes to GLI1-Driven EMT in Hepatocellular Carcinoma , 2014, PloS one.

[88]  M. Lisanti,et al.  Caveolin-1 and breast cancer: a new clinical perspective. , 2012, Advances in experimental medicine and biology.

[89]  F. Sotgia,et al.  Caveolae and signalling in cancer , 2015, Nature Reviews Cancer.

[90]  A. Trumpp,et al.  Mechanisms of Disease: cancer stem cells—targeting the evil twin , 2008, Nature Clinical Practice Oncology.

[91]  M. Chintala,et al.  Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells , 2016, Journal of breast cancer.

[92]  Jianqun Lu,et al.  Autophagy: novel applications of nonsteroidal anti‐inflammatory drugs for primary cancer , 2017, Cancer medicine.

[93]  W. Haefeli,et al.  Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[94]  A. Jemal,et al.  Breast cancer statistics, 2017, racial disparity in mortality by state , 2017, CA: a cancer journal for clinicians.

[95]  Fusheng Yang,et al.  Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions , 2005, Neurobiology of Aging.

[96]  S. Patra,et al.  Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators , 2014, Tumor Biology.

[97]  O. Salis,et al.  Cytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CAV1. , 2014, Cancer biotherapy & radiopharmaceuticals.

[98]  Xin Liang,et al.  PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing , 2018, Cell Death & Disease.

[99]  F. Sotgia,et al.  Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. , 2017, Seminars in oncology.

[100]  M. Weitzman,et al.  Caveolin‐1 Mediates Inflammatory Breast Cancer Cell Invasion via the Akt1 Pathway and RhoC GTPase , 2015, Journal of cellular biochemistry.

[101]  M. Thompson,et al.  The role of caveolae in the pathophysiology of lung diseases , 2014, Expert review of respiratory medicine.

[102]  B. Annabi,et al.  Caveolin and cavin family members: dual roles in cancer. , 2014, Biochimie.

[103]  Bin Liu,et al.  MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer , 2018, Experimental and therapeutic medicine.

[104]  Honglei Chen,et al.  Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer , 2020, PloS one.

[105]  G. Riggins,et al.  Caveolin-1, caveolae, and glioblastoma. , 2012, Neuro-oncology.

[106]  Yongxiang Yin,et al.  Tubeimoside V sensitizes human triple negative breast cancer MDA-MB-231 cells to anoikis via regulating caveolin-1-related signaling pathways. , 2018, Archives of biochemistry and biophysics.

[107]  Weilong Chang,et al.  Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer BT474 cells. , 2014, Molecular medicine reports.

[108]  Li-Xia Xiong,et al.  Downregulation of caveolin-1 upregulates the expression of growth factors and regulators in co-culture of fibroblasts with cancer cells , 2015, Molecular medicine reports.

[109]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[110]  Brandon C. Jones,et al.  Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1–Dependent Trafficking of Integrins , 2014, Molecular Cancer Research.

[111]  T. Inamoto,et al.  Prognostic significance of tumor/stromal caveolin‐1 expression in breast cancer patients , 2011, Cancer science.

[112]  Fan Wang,et al.  Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction. , 2016, Atherosclerosis.

[113]  L. Esserman,et al.  Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer , 2018, npj Breast Cancer.

[114]  L. Chamberlain.  Detergents as tools for the purification and classification of lipid rafts , 2004, FEBS letters.

[115]  Fengxue Zhang,et al.  Caveolin-1: An Oxidative Stress-Related Target for Cancer Prevention , 2017, Oxidative medicine and cellular longevity.

[116]  P. Chanvorachote,et al.  Caveolin-1 Regulates Endothelial Adhesion of Lung Cancer Cells via Reactive Oxygen Species-Dependent Mechanism , 2013, PloS one.

[117]  King-Jen Chang,et al.  Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells , 2018, Scientific Reports.

[118]  M. Hamberg,et al.  Omega‐3 fatty acid supplementation delays the progression of neuroblastoma in vivo , 2011, International Journal of Cancer.

[119]  Y. Surh,et al.  The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets. , 2008, Asia Pacific journal of clinical nutrition.

[120]  Eunhee Kim,et al.  Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics , 2015, Biomolecules & therapeutics.

[121]  M. Gilardi,et al.  Caveolin-1, breast cancer and ionizing radiation. , 2015, Cancer genomics & proteomics.

[122]  Yeul-Hong Kim,et al.  Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different Mechanisms , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[123]  M. Chintala,et al.  Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[124]  G. Semenza,et al.  The hypoxic tumor microenvironment: A driving force for breast cancer progression. , 2016, Biochimica et biophysica acta.

[125]  Xiaoyan Liu,et al.  Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy. , 2016, Current drug targets.

[126]  Kelly M. Bailey,et al.  Caveolin-1 Up-regulation during Epithelial to Mesenchymal Transition Is Mediated by Focal Adhesion Kinase* , 2008, Journal of Biological Chemistry.

[127]  D. Rodriguez,et al.  The caveolin-1 connection to cell death and survival. , 2013, Current molecular medicine.

[128]  M. Sarem,et al.  Liposomal Treatment of Cancer Cells Modulates Uptake Pathway of Polymeric Nanoparticles by Altering Membrane Stiffness. , 2018, Small.

[129]  M. Konstadoulakis,et al.  Breast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of Caveolin-1 and CXCR4 , 2014, Clinical & Experimental Metastasis.

[130]  A. Schimmer,et al.  Anoikis resistance and tumor metastasis. , 2008, Cancer letters.

[131]  George C Tseng,et al.  Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures. , 2018, Cancer research.

[132]  A. Aboussekhra,et al.  Caffeine Mediates Sustained Inactivation of Breast Cancer-Associated Myofibroblasts via Up-Regulation of Tumor Suppressor Genes , 2014, PloS one.

[133]  Kevin Struhl,et al.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.

[134]  Jie Wu,et al.  Clinical Significance of Gli-1 And Caveolin-1 Expression in the Human Small Cell Lung Cancer , 2018, Asian Pacific journal of cancer prevention : APJCP.

[135]  A. Chatterjee,et al.  Extracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3 , 2013, Cell communication & adhesion.

[136]  Monilola A. Olayioye,et al.  Rho regulation: DLC proteins in space and time. , 2015, Cellular signalling.

[137]  R. Kandpal,et al.  Rho GTPase activating proteins in cancer phenotypes. , 2006, Current protein & peptide science.

[138]  B. Fraass,et al.  Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers , 2016, PloS one.

[139]  G. Hortobagyi,et al.  Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer , 2006, Nature Clinical Practice Oncology.

[140]  S. Anwar,et al.  Caveolin-1 in Breast Cancer: Single Molecule Regulation of Multiple Key Signaling Pathways. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[141]  A. Gilmore,et al.  Anoikis. , 2000, Cell death and differentiation.

[142]  M. Peter,et al.  The role of CD95 and CD95 ligand in cancer , 2015, Cell Death and Differentiation.

[143]  M. Beckmann,et al.  Characterization of Molecular Subtypes of Paget Disease of the Breast Using Immunohistochemistry and In Situ Hybridization. , 2018, Archives of pathology & laboratory medicine.

[144]  Wen-Chao Liu,et al.  Caveolin-1 Limits the Contribution of BKCa Channel to MCF-7 Breast Cancer Cell Proliferation and Invasion , 2014, International journal of molecular sciences.

[145]  Fangfang Liu,et al.  Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome , 2014, Virchows Archiv.

[146]  M. Ahram,et al.  Expression of androgen receptor in invasive ductal breast carcinomas: a clinicopathological study from Jordan , 2018, Annals of Saudi medicine.

[147]  N. Nafisi,et al.  The Relationship Between 6 Polymorphisms of Caveolin‐1 Gene and the Risk of Breast Cancer , 2018, Clinical breast cancer.

[148]  Amareshwar T. K. Singh,et al.  Apoptosis: A Target for Anticancer Therapy , 2018, International journal of molecular sciences.

[149]  W. Hanneman,et al.  Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor , 2014, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[150]  K. Tang,et al.  Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways. , 2017, Biochimica et biophysica acta. Molecular cell research.

[151]  M. Humbert,et al.  Genetics of pulmonary hypertension in the clinic , 2017, Current opinion in pulmonary medicine.

[152]  Hans Clevers,et al.  The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.

[153]  C. Munaut,et al.  Dynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4‐MMP) in breast cancer cells , 2016, The FEBS journal.

[154]  R. Perona,et al.  A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer , 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[155]  F. Loganzo,et al.  Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1) , 2017, Molecular Cancer Therapeutics.

[156]  R. Hanafi,et al.  miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1 , 2016, Journal of clinical and translational hepatology.

[157]  Fengxue Zhang,et al.  Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin‐1‐targeting oxidant damage , 2018, Journal of cellular physiology.

[158]  C. Indolfi,et al.  miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes , 2018, Diabetes.

[159]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[160]  Yong‐Nyun Kim,et al.  Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis , 2012, International journal of cell biology.

[161]  Fei Wang,et al.  Downregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of no special type: Clinicopathological associations and prognostic relevance , 2017, Oncology letters.

[162]  S. Tian,et al.  Different Role of Caveolin-1 Gene in the Progression of Gynecological Tumors , 2019, Asian Pacific journal of cancer prevention : APJCP.

[163]  I. Ellis,et al.  Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype , 2008, British Journal of Cancer.

[164]  F. Sotgia,et al.  Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. , 2012, Annual review of pathology.

[165]  C. Chotwiwatthanakun,et al.  The key molecular events during Macrobrachium rosenbergii nodavirus (MrNV) infection and replication in Sf9 insect cells , 2016, Virus Research.

[166]  M. Moyer,et al.  Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis , 2010, Nature.

[167]  Lin Fang,et al.  Activated estrogen receptor-mitogen-activated protein kinases cross talk confer acquired resistance to lapatinib , 2015, Thoracic cancer.

[168]  S. Aktaş,et al.  Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer , 2017, Pathology & Oncology Research.

[169]  R. Gómez,et al.  Bisphenol A Induces Migration through a GPER-, FAK-, Src-, and ERK2-Dependent Pathway in MDA-MB-231 Breast Cancer Cells. , 2016, Chemical research in toxicology.

[170]  H. Hsu,et al.  Fucose-containing fraction of Ling-Zhi enhances lipid rafts-dependent ubiquitination of TGFβ receptor degradation and attenuates breast cancer tumorigenesis , 2016, Scientific Reports.

[171]  F. Acconcia,et al.  Modulation of 17β‐Estradiol Signaling on Cellular Proliferation by Caveolin‐2 , 2016, Journal of cellular physiology.

[172]  P. Tan,et al.  Caveolin-1 expression as a prognostic marker in triple negative breast cancers of Asian women , 2017, Journal of Clinical Pathology.